Metraipolis › archive › dc_55aeef2e189c

Neoadjuvant therapy for hepatocellular carcinoma: emerging combinations and biomarker challenges — Europe PMC PMID:42519345

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42519345
DOI
10.3389/fimmu.2026.1809834
License (as archived)
solo-consultazione
Archived
2026-10-18T11:01:45.220Z
SHA-256 of the archived text
829e473e4c7842054e251df922784d0537c12ea14b60b6877c381d98abb8e50a
Stable URL of this page
https://metraipolis.com/documento/dc_55aeef2e189c

How to cite

Neoadjuvant therapy for hepatocellular carcinoma: emerging combinations and biomarker challenges — Europe PMC PMID:42519345 — Europe PMC (en), https://europepmc.org/article/MED/42519345 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_55aeef2e189c (Metraipolis archive dc_55aeef2e189c, sha256 829e473e4c7842054e251df922784d0537c12ea14b60b6877c381d98abb8e50a)
BibTeX
@misc{dc55aeef2e189c,
  title = {Neoadjuvant therapy for hepatocellular carcinoma: emerging combinations and biomarker challenges — Europe PMC PMID:42519345},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42519345},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_55aeef2e189c; sha256 829e473e4c7842054e251df922784d0537c12ea14b60b6877c381d98abb8e50a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42519345. Agents can read the archived copy with the MCP tool read_document.